Inflammation  >>  dilmapimod (SB-681323)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dilmapimod (SB-681323) / GSK
NCT00439881: A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single Dose

Completed
1
16
Europe
SB-681323
GlaxoSmithKline
Arthritis, Rheumatoid, Inflammation
 
 

Download Options